Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-23-010832

CHIEF EXECUTIVE OFFICER sold 10,000 shares at $18.00 ($180,000)

  • CHIEF EXECUTIVE OFFICER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

NOYES TIMOTHY P · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-03 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $2.14 $21,400 10,000 D
2023-07-03 Sale : show line 2 in the form 10b5-1 −10,000 $18.00 $180,000 0 D
Open-market sales · 10,000 sh · avg $18.00 · $180,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-07-03 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −10,000 393,381 D
Loading xslF345X04/form4-07052023_060701.xml…